Charles River Laboratories International CEO James Foster's 2021 pay rises 2% to $14M

Charles River Laboratories International reports 2021 executive compensation

By ExecPay News

Published: March 30, 2022

Charles River Laboratories International reported fiscal year 2021 executive compensation information on March 30, 2022.
In 2021, five executives at Charles River Laboratories International received on average a compensation package of $6.3M, a 27% increase compared to previous year.
Average pay of disclosed executives at Charles River Laboratories International
James C. Foster, Chief Executive Officer, received $14M in total, which increased by 2% compared to 2020. 61% of Foster's compensation, or $8.4M, was in stock awards. Foster also received $1.9M in non-equity incentive plan, $2.1M in option awards, $1.4M in salary, as well as $58K in other compensation.
For fiscal year 2021, the median employee pay was $51,848 at Charles River Laboratories International. Therefore, the ratio of James C. Foster's pay to the median employee pay was 264 to one.
Joseph LaPlume, Corporate Executive Vice President Corporate Development and Strategy, received a compensation package of $7.9M, which increased by 191% compared to previous year. 82% of the compensation package, or $6.5M, was in stock awards.
David R. Smith, Chief Financial Officer, earned $3.6M in 2021, a 16% increase compared to previous year.
Birgit Girshick, Chief Operating Officer, received $3.2M in 2021, which increases by 21% compared to 2020.
William D. Barbo, Corporate Executive Vice President, Chief Commercial Officer, earned $2.8M in 2021, a 9% increase compared to previous year.
Charles River Laboratories International's fiscal year ends on December 25.

Related executives

James Foster

Charles River Laboratories International

Chief Executive Officer

David Smith

Charles River Laboratories International

Chief Financial Officer

William Barbo

Charles River Laboratories International

Corporate Executive Vice President, Chief Commercial Officer

Birgit Girshick

Charles River Laboratories International

Chief Operating Officer

Joseph LaPlume

Charles River Laboratories International

Corporate Executive Vice President Corporate Development and Strategy

You may also like

Source: SEC filing on March 30, 2022.